Table 2.
Biochemical parameters of the groups
| Parameters | Groups | N | Mean (SD) | P value |
|---|---|---|---|---|
| ALP (U/L) | Control | 8 | 137.88 (37.12) | > 0.05a |
|
| ||||
| PRP-1 | 8 | 61.38 (11.5) | ||
|
| ||||
| PRP-2 | 8 | 89.88 (72.07) | ||
|
| ||||
| Ca (mg/dl) | Control | 8 | 10.17 (0.57) | |
|
| ||||
| PRP-1 | 8 | 9.88 (1.3) | ||
|
| ||||
| PRP-2 | 8 | 10.14 (1.75) | ||
|
| ||||
| P (mg/dl) | Control | 8 | 6.18 (0.47) | |
|
| ||||
| PRP-1 | 8 | 5.86 (0.56) | ||
|
| ||||
| PRP-2 | 8 | 6.19 (1.48) | ||
|
| ||||
| Cr (mg/dl) | Control | 8 | 0.55 (0.08) | |
|
| ||||
| PRP-1 | 8 | 0.52 (0.09) | ||
|
| ||||
| PRP-2 | 8 | 0.57 (0.12) | ||
|
| ||||
| ALP (U/L) | Controls | 8 | 137.88 (37.12) | > 0.05b |
|
| ||||
| Test (PRP-1 and PRP-2) | 16 | 75.63 (51.98) | ||
|
| ||||
| Ca (mg/dl) | Controls | 8 | 10.17 (0.57) | |
|
| ||||
| Test (PRP-1 and PRP-2) | 16 | 10.01 (1.49) | ||
|
| ||||
| P (mg/dl) | Controls | 8 | 6.18 (0.47) | |
|
| ||||
| Test (PRP-1 and PRP-2) | 16 | 6.03 (1.09) | ||
|
| ||||
| Cr (mg/dl) | Controls | 8 | 0.56 (0.08) | |
|
| ||||
| Test (PRP-1 and PRP-2) | 16 | 0.55 (0.1) | ||
aNot statistically significant at level P < 0.05 (One-way ANOVA).
bNot statistically significant at level P < 0.05 (Student's t-test).
N = number of subjects; SD = standard deviation; PRP = propranolol; ALP = alkaline phosphatase; Ca = calcium; P = phosphorus; Cr = creatinine; PRP-1 = propranolol dose-1; PRP-2 = propranolol dose-2.